Skip to content

Prismatic adaptation for the treatment of dyslexia

Prismatic adaptation coupled with cognitive training: a novel non-phonological treatment for developmental dyslexia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN15190285
Enrollment
150
Registered
2023-11-21
Start date
2022-06-01
Completion date
Unknown
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Developmental dyslexia Mental and Behavioural Disorders

Interventions

Prismatic adaptation, i.e., a visuomotor adaptation technique, combined with cognitive training will be delivered by means of the MindLenses (TM) device to study participants in order to evaluate the

Sponsors

Policlinico Umberto I
Lead Sponsor

Eligibility

Sex/Gender
All
Age
13 Years to 17 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosis of developmental dyslexia 2. Total IQ above the low average range (=80), as confirmed on the Wechsler intelligence scale for children – fourth edition (WISC-IV) 3. Either Working Memory Index (WMI) or Processing Speed Index (PSI) below the low average range (80), or both

Exclusion criteria

Exclusion criteria: 1. Presence of other neurodevelopmental disorders, particularly attention-deficit/hyperactivity disorder (ADHD) 2. Any major comorbid psychiatric disorder such as schizophrenia, bipolar disorder, or major depression disorder a diagnosis of active epilepsy 3. Physical disabilities that could impair the use of the study instruments

Design outcomes

Primary

MeasureTime frame
1. Reading speed, assessed in syllables per second and calculated using this formula (syllables read correctly/seconds) by reading out loud the text included in the MT-Avanzate-3 battery or the in the MT-16-19 battery. Assessed at baseline, 10 weeks after treatment start, 6 months after treatment end, 12 months after treatment end. 2. Reading accuracy, expressed as percentage value (%) of correct words and pseudowords read out loud from the DDE-2 battery. Assessed at baseline, 10 weeks after treatment start, 6 months after treatment end, 12 months after treatment end.

Secondary

MeasureTime frame
1. Working memory index, assessed as quotient (mean=100, 1 SD=15) provided by the Wechsler Intelligence Scale for Children - Fourth Edition. Assessed at baseline, 10 weeks after treatment start, 6 months after treatment end, 12 months after treatment end. 2. Processing speed index, assessed as quotient (mean=100, 1 SD=15) provided by the Wechsler Intelligence Scale for Children - Fourth Edition. Assessed at baseline, 10 weeks after treatment start, 6 months after treatment end, 12 months after treatment end.

Countries

Italy

Contacts

Public ContactGiulia;Massimiliano Conte;Oliveri

;

giulia.conte@uniroma1.it;massimiliano.oliveri@unipa.it+39 (0)6 49972969;+39 (0)91 23865700

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 15, 2026